Litigation Details for Meijer, Inc. v. Endo Health Solutions, Inc. (N.D. Ill. 2014)
✉ Email this page to a colleague
Meijer, Inc. v. Endo Health Solutions, Inc. (N.D. Ill. 2014)
Docket | ⤷ Try a Trial | Date Filed | 2014-09-19 |
Court | District Court, N.D. Illinois | Date Terminated | |
Cause | 15:1 Antitrust Litigation | Assigned To | Harry Daniel Leinenweber |
Jury Demand | Plaintiff | Referred To | |
Parties | ENDO PHARMACEUTICALS, INC. | ||
Patents | 7,276,250 | ||
Attorneys | Matthew T. Slater | ||
Firms | BR>Trial Bar Status: Not a Member | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Meijer, Inc. v. Endo Health Solutions, Inc.
Details for Meijer, Inc. v. Endo Health Solutions, Inc. (N.D. Ill. 2014)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2014-09-19 | 1 | what ultimately issued as United States Patent No. 7,276,250 entitled sustained release formulations …that is, while the patent litigation was still pending); or (b) after winning the patent suit; or (c) via… normal patent infringement litigation settlements, the alleged infringer would pay the patent holder.… the manufacturer’s patents for accuracy or trustworthiness. In listing patents in the Orange Book, …applicant for patent infringement. If the brand manufacturer initiates a patent infringement | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |